603590.SHG · Beijing Konruns Pharmaceutical Co.,Ltd

Beijing Konruns Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 3.3% below its 200 day moving average.

From a valuation standpoint, the stock is 29.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.8.

Beijing Konruns Pharmaceutical Co.,Ltd's total revenue sank by 15.1% to $259M since the same quarter in the previous year.

Its net income has dropped by 33.3% to $42M since the same quarter in the previous year.

Finally, its free cash flow fell by 148.0% to $-24M since the same quarter in the previous year.

Based on the above factors, Beijing Konruns Pharmaceutical Co.,Ltd gets an overall score of 1/5.